| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 20,522.0 | 17,361.0 |
| Profit before tax | 3,000.0 | 1,210.0 |
| Net income | 2,397.0 | 896.0 |
| EPS (diluted, $ a share) | $3.67 | $1.22 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +167.5% |
|---|---|
| Revenue, year on year | +18.2% |
10-Q filed with the SEC, NYSE: MET. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Metlife Inc: key numbers
- Share price
- $101.45Close, Nov 16
- Market cap
- $63.8B
- Shares outstanding
- 628.44MLatest SEC cover page
- Sector
- Finance
- Industry
- Life InsuranceSIC 6311
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Metlife Inc
All →Metlife Dividend
MetLife, Inc. declared quarterly cash dividends on its Series A, Series E, and Series F non-cumulative preferred stock. The dividends are payable on December 15, 2026, to shareholders of record as of November 30, 2026.
Metlife President & CEO Michel Khalaf Sells $19.3M of Stock
Michel Khalaf, President & CEO, sold 187,425 shares of Metlife Inc at $102.97 a share, worth $19.3M in total on Nov 10, 2026. Shares held after the trade: 759,013 (-19.8%).
- Value
- $19.3M
- Shares
- 187,425
- Price
- $102.97
- Role
- President & CEO
- Holding change
- -19.8%
- Trade date
- Nov 10, 2026
Metlife $4B Debt Financing with Bank of America, N.A.
MetLife, Inc. and its subsidiary MetLife Funding, Inc. entered into a $4.0 billion amended and restated credit agreement with a syndicate of lenders led by Bank of America. The facility, which can be increased to $5.5 billion, is intended for general corporate purposes and has a maturity date of November 7, 2031. This agreement replaces the previous credit facility dated May 8, 2023.
- Value
- $4B
- Counterparty
- Bank of America, N.A.
- Term
- through Nov 2031
Metlife Financial Results
MetLife reported record third-quarter 2026 results with net income of $2.4 billion and adjusted earnings per share of $2.85, the highest in the company's history. The performance was driven by broad-based volume growth across all six business segments, favorable underwriting, and higher variable investment income.
- Term
- Q3 2026
“We delivered the highest quarterly adjusted earnings per share in MetLife’s history in the third quarter, demonstrating the strength of our New Frontier strategy and discipline of our execution. Revenue rose in every business segment, and solid underwriting, volume growth and higher investment returns lifted earnings.”
Michel Khalaf, President and Chief Executive Officer
Metlife Business Update
MetLife provided a preliminary estimate for its Q3 2026 variable investment income, expecting it to be at least $600 million (pre-tax). This figure is being disclosed ahead of the formal quarterly earnings release scheduled for November 4, 2026, and is compared against the company's full-year 2026 guidance of approximately $1.6 billion.
- Term
- Q3 2026